An interventional study of Pain relief skills training and Health Education in Chronic Pain, sponsored by Washington State University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Washington State University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,283 studies in Chronic Pain with a site in United States — 257 open to participants now, 348 under way, 7 of them phase 3. Chronic Pain · United States.
Among the 1,283 studies in Chronic Pain with a site in United States, this one is the 84th largest by planned enrollment of the 1,092 interventional ones that give a count, is one of 12 that started in 2027, is one of 803 with no phase, reaches primary completion later than 337 of the 347 other live ones, and was the 1,277th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →257 of the 1,283 studies in Chronic Pain with a site in United States are open now. Recruiting first, the newest first:
University of Oklahoma · Sites in United States
Ages 18–120
Virginia Polytechnic Institute and State University · Sites in United States
Ages 18–65
Stanford University · Sites in United States
Ages 18+ · Women only
University of Massachusetts, Boston · Sites in United States
Ages 65+
Stanford University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,283 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 81 · Phase 2 112 · Phase 3 72 · Phase 4 50
First in 1992; this study’s year is marked. 12 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 400 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 60 across the 1,092 interventional studies, 100 across the 189 observational. Of the 848 that completed or were terminated, 386 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
209 of 1,283 have an industry lead sponsor. The 10 most frequent:
Washington State University is the lead sponsor of 83 studies on the registry; 16 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 4 (57%) have results posted.
Washington State University has 4 studies filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
139 of the studies in Chronic Pain with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05703178Phase 3Northwestern UniversityWeb-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia | 2026-11-30 |
| NCT06091202Phase 3Oregon Health and Science UniversityTele-Collaborative Outreach to Rural Patients With Chronic Pain | 2027-05-01 |
| NCT05459402Phase 3University of Maryland, BaltimoreDivided or Single Exposure (DOSE) Study | 2027-06-01 |
| NCT02979574Memorial Sloan Kettering Cancer CenterPEACE: Comparing Chronic Pain Treatment Options | 2026-11 |
| NCT03984565Staci Gruber, Ph.D.PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product | 2026-11 |
Add all 139 to your calendar (.ics) → With an account.
Among the 1,283 studies in Chronic Pain with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this randomized clinical trial is to learn if a nurse-delivered psychoeducational pain management skills intervention [Empowered Relief] can improve pain outcomes for adults with chronic pain who live in rural communities The main question[s] it aims to answer are:
Does nurse-delivered Empowered Relief improve pain intensity and pain interference more than a health education intervention after 3 months? Does nurse-delivered Empowered Relief improve pain catastrophizing, pain self-efficacy, and relaxation response more than a health education intervention after 3 months? Does nurse-delivered Empowered Relief improve sleep disturbance, depression, fatigue, and anxiety more than a health education intervention after 3 months?
Participants will:
Attend either a single-session 2-hour Empowered Relief class or a Health Education intervention.
Complete assessments measuring pain and related symptoms with online surveys immediately post-intervention and 3 months later.
Receive daily prompts to practice skills from the intervention.
This study will be conducted as a randomized controlled trial comparing effects of Empowered Relief (ER) to a Health Education (HE) session for participants with chronic pain recruited from rural clinics when ER is provided by ER-trained nurses. Participants (N=400) will complete an online eligibility form to screen for inclusion and exclusion criteria and advance to a consent process if eligible. Eight nurses recruited from rural communities will receive ER training facilitated by Stanford Pain Relief Innovations Lab. Recruitment will occur through three partnering rural health clinics. Study participants will be asked to complete a baseline survey of demographics and health variables and then randomized to one of two study groups: ER and HE. Participants randomized to the ER group will complete a Health Insurance Portability and Accountability Act [HIPAA] compliant, password protected Zoom ER class delivered by an ER-trained rural nurse instructor. Participants assigned to HE will receive a standardized online self-paced intervention.
The criteria were revised on the registry on Oct 15, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained registered nurse (RN).
Behavioral: Pain relief skills training
Participants randomized to the digital Health Education (HE) Control group will receive an educational intervention similar in time and attention to compare with the experimental treatment group.
Other: Health Education
Rural RN-delivered psychoeducational pain relief skills group intervention includes development of a personalized plan, downloading a corresponding app for daily and unlimited use, and daily text messages for 90 days..
A digital health education intervention is roughly matched for time, attention, and daily text for 90 days.
Pain intensity
Patient-reported outcomes measures (PROMIS) Pain Intensity short form 1a to measure reported average pain intensity over the previous seven days using an 11-point Likert scale (0 = no pain; 10 = worst imaginable pain). The minimum value is 0 and maximum value is 10 with higher scores meaning a worse outcome.
Time frame: 3 months
Pain interference
Patient-reported outcomes measures (PROMIS) 8-item pain interference measure to collect reported pain interference with various activities in the previous seven days on a scale of 1 to 5 (1 = not at all; 5 = very much); the minimum value is 8 and maximum value is 40 with higher scores meaning a worse outcome.
Time frame: 3 months
Pain self-efficacy
10-item Pain Self Efficacy Questionnaire (PSEQ) is employed to measure the confidence of participants to conduct activities (e.g., work, accomplish goals) despite experiencing persistent pain. Each item is rated on a 7-point Likert scale (0 = not at all confident; 6 = completely confident). Scores are summed with higher values indicating better pain self-efficacy with minimum value of 0 and maximum value of 60.
Time frame: 3 months
Pain catastrophizing scale
13 item Pain Catastrophizing Scale (PCS) is employed to measure the degree to which one experiences catastrophic thinking related to pain with each item rated on a 5-point Likert scale (0 = not at all; 4 = all the time). Scores are summed with higher values indicating greater and less favorable levels of catastrophizing with minimum value of 0 and maximum value of 52.
Time frame: 3 months
Calm scale
5-item scale to measure how confident one is in reaching a calm, relaxed state under certain conditions (such as, when in pain, when anxious). Each item is rated on a 7-point Likert scale (0 = not at all confident; 6 = completely confident) with a minimum value of 0 and maximum value of 30 with higher scores meaning a more favorable outcome of higher confidence.
Time frame: 3 months
Sleep disturbance
Patient-reported outcomes measures (PROMIS) Sleep Disturbance 6-item scale that describes sleep quality and patterns. Sleep quality is rated on a scale of 5 to 1 (5 = very poor; 1 = very good) and sleep patterns on a scale of 1 to 5 (1 = not at all; 5 = very much). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.
Time frame: 3 months
Depression
Patient-reported outcomes measures (PROMIS) Depression 6-item scale measured frequency of self-reported depressive symptoms on a scale from 1 to 5 (1 = never; 5 = always). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.
Time frame: 3 months
Fatigue
Patient-reported outcomes measures (PROMIS) Fatigue 6-item scale in which the frequency of fatigue symptoms are rated on a scale from 1 to 5 (1 = never; 5 = very much). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.
Time frame: 3 months
Anxiety
Patient-reported outcomes measures (PROMIS) Anxiety 6-item scale in which the frequency of anxiety symptoms are rated on a scale from 1 to 5 (1 = never; 5 = always). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.
Time frame: 3 months
Plan to share: Yes — All outcomes data will be available to share pending appropriate data use agreements.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: At study end 2031 and indefinitely.
Access criteria: Principal investigators will grant access to those with scientific interest to all collected data via the process set by Stanford Data Repository
Data sharing details ↗ · sdr.library.stanford.edu
Start is estimated for Mar 2027; primary completion for Sep 2030, 42 months later.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 42 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington State University